(Q59195965)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Massimo Serra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Pancras C.W. Hogendoorn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

7

Hans Gelderblom

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Jens H W Pahl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S Eriaty N Ruslan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Emilie P Buddingh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Susy J Santos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

R Maarten Egeler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marco W Schilham

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Arjan C Lankester

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

16 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

432-441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

10.1158/1078-0432.CCR-11-2277

16 January 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22090361%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference